Anand Bhaskar — SEC Form 4 filings

SEC reporting owner CIK 1890784. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-12.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-04-04 to 2026-01-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Summit Therapeutics Inc. (SMMT)Chief Accounting Officer78

Form 4 filings — Anand Bhaskar

FiledFormIssuerReported transactionsSource
2026-01-124Summit Therapeutics Inc. (SMMT)Grant/award (A): 30,000 (derivative)EDGAR
2025-10-234Summit Therapeutics Inc. (SMMT)Grant/award (A): 26,680 @ $18.74EDGAR
2025-09-194Summit Therapeutics Inc. (SMMT)Grant/award (A): 50,000 (derivative)EDGAR
2025-05-014Summit Therapeutics Inc. (SMMT)Grant/award (A): 600,000 (derivative) · Grant/award (A): 75,000 (derivative)EDGAR
2025-01-144Summit Therapeutics Inc. (SMMT)Grant/award (A): 75,000 (derivative)EDGAR
2024-09-134Summit Therapeutics Inc. (SMMT)Grant/award (A): 22,026 @ $22.70EDGAR
2024-04-044Summit Therapeutics Inc. (SMMT)Grant/award (A): 600,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1890784 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →